Skip to main content
. 2020 Jan 4;18:6. doi: 10.1186/s12957-019-1775-5

Fig. 4.

Fig. 4

Recurrence hazard analysis according to clinicopathological characteristics. a pathological types; b primary tumor thickness of cutaneous melanoma; c: ulceration of primary lesion in cutaneous melanoma; d regional lymph node status for cutaneous melanoma; e wound infection of cutaneous melanoma; f adjuvant therapy in cutaneous melanoma; g adjuvant therapy in mucosal melanoma